Servicios Personalizados
Revista
Articulo
Español (pdf)
Artículo en XML
Referencias del artículo
Traducción automática
Enviar artículo por emailIndicadores
Citado por SciELO 
Accesos
Links relacionados
Similares en
SciELO
Compartir
Permalink
Acta médica Grupo Ángeles
versión impresa ISSN 1870-7203
Resumen
LUGO BAUTISTA, Karla Sharon; MEDINA RODRIGUEZ, José Carlos; RODRIGUEZ WEBER, Federico Leopoldo y DIAZ GREENE, Enrique Juan. Depressive symptoms as predictors of treatment adherence in patients with type 2 diabetes: a cross-sectional study. Acta méd. Grupo Ángeles [online]. 2023, vol.21, n.1, pp.28-31. Epub 09-Jun-2023. ISSN 1870-7203. https://doi.org/10.35366/109017.
Introduction:
type 2 diabetes (T2D) is a condition with a high disease burden and is frequently accompanied by depressive symptoms, which could affect treatment adherence.
Objective:
a cross-sectional study was done to measure the impact of depressive symptoms on adherence to treatment of people with T2D.
Material and methods:
sociodemographic data were collected; the Hamilton depression scale (HADS) was used to measure depressive symptoms, and the Morisky medication adherence scale (MMAS) to assess adherence.
Results:
correlations were found between the male gender and the number of antidiabetic medications, physical activity, and several medications, and HADS score and low adherence. A significant regression was found between the HADS and MMAS scores.
Conclusions:
depressive symptoms were predictors of adherence in patients with T2D, and associations were found between sociodemographic and clinical variables.
Palabras llave : depression; diabetes mellitus; medication adherence.
